Sinovac Biotech Co., Ltd
Sinovac Biotech Co., Ltd
Explore linked clinical trials.19 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase IV Clinical Trial of Influenza Vaccine (Split Virion), Inactivatedin (Anflu®) Pregnant Women (AnFLU-PREG) | Infections, RNA Virus Infections, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Not yet recruiting | Phase 4 | 2026-09-21 | NCT07832201 | |
| Bridging Clinical Trial of EV71 Vaccine in Vietnamese Children | Infections, Picornaviridae infectious disease, RNA Virus Infections, coxsackievirus infectious disease, enterovirus infectious disease, hand, foot and mouth disease, viral infectious disease | Not yet recruiting | Not applicable | 2026-09-01 | NCT07793175 | |
| Phase Ⅲ Clinical Trial of an Inactivated Hepatitis A Vaccine | Digestive System Diseases, hepatitis, liver disorder | Recruiting | Phase 3 | 2026-08-28 | NCT07793227 | |
| Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 2-6 Years | Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neisseriaceae Infections, Neuroinflammatory Diseases, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-negative bacterial infections, meningitis, meningococcal infection, meningococcal meningitis, nervous system disorder | Active, not recruiting | Phase 3 | 2026-08-10 | NCT07505888 | |
| Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months | Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neisseriaceae Infections, Neuroinflammatory Diseases, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-negative bacterial infections, meningitis, meningococcal infection, meningococcal meningitis, nervous system disorder | Recruiting | Phase 3 | 2026-08-10 | NCT07505836 | |
| Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 6-11 Months | Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neisseriaceae Infections, Neuroinflammatory Diseases, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-negative bacterial infections, meningitis, meningococcal infection, meningococcal meningitis, nervous system disorder | Recruiting | Phase 3 | 2026-08-10 | NCT07505823 | |
| Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 3-5 Months | Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neisseriaceae Infections, Neuroinflammatory Diseases, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-negative bacterial infections, meningitis, meningococcal infection, meningococcal meningitis, nervous system disorder | Recruiting | Phase 3 | 2026-08-10 | NCT07505810 | |
| Protective Efficacy , Immunogenicity and Safety of the Tetravalent Inactivated Enterovirus Vaccine (Vero Cell). | Echovirus infectious disease, Infections, Picornaviridae infectious disease, RNA Virus Infections, coxsackievirus infectious disease, enterovirus infectious disease, hand, foot and mouth disease, herpangina, viral infectious disease | Not yet recruiting | Phase 3 | 2026-05-28 | NCT07611513 | |
| Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine | Infections, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, myelitis, nervous system disorder, neuromuscular disease, poliomyelitis, spinal cord disorder, viral infectious disease | Recruiting | Phase 4 | 2026-03-09 | NCT07457060 | |
| Study to Evaluate the Safety of a Lyophilized RSV mRNA Vaccine | RSV; mRNA Vaccine | Not yet recruiting | Phase 1 | 2026-02-18 | NCT07418229 | |
| Phase IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies Vaccine | Infections, Mononegavirales infectious disease, RNA Virus Infections, Rhabdoviridae infectious disease, rabies, viral infectious disease | Not yet recruiting | Phase 3 | 2026-02-17 | NCT07416110 | |
| Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine | DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, herpes zoster, viral infectious disease | Recruiting | Phase 1 / Phase 2 | 2026-02-10 | NCT07400003 | |
| Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Pregnant Women | Infections, RNA Virus Infections, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Recruiting | Phase 3 | 2026-01-28 | NCT07211152 | |
| Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations | Infections, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, myelitis, nervous system disorder, neuromuscular disease, poliomyelitis, spinal cord disorder, viral infectious disease | Recruiting | Phase 4 | 2026-01-21 | NCT07354269 | |
| Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen | Infections, Mononegavirales infectious disease, RNA Virus Infections, Rhabdoviridae infectious disease, rabies, viral infectious disease | Not yet recruiting | Phase 3 | 2025-07-09 | NCT07055893 | |
| Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell) | Infections, Mononegavirales infectious disease, RNA Virus Infections, Rhabdoviridae infectious disease, rabies, viral infectious disease | Not yet recruiting | Phase 2 | 2025-07-09 | NCT07055880 | |
| Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen | Infections, Mononegavirales infectious disease, RNA Virus Infections, Rhabdoviridae infectious disease, rabies, viral infectious disease | Not yet recruiting | Phase 3 | 2025-07-08 | NCT07055295 | |
| Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell) | Infections, Picornaviridae infectious disease, RNA Virus Infections, coxsackievirus infectious disease, enterovirus infectious disease, hand, foot and mouth disease, viral infectious disease | Recruiting | Phase 3 | 2025-01-01 | NCT06734832 | |
| Immunogenicity and Safety of Hepatitis A Among People Aged 18-50 Years Old | Digestive System Diseases, Infections, Picornaviridae infectious disease, RNA Virus Infections, enterovirus infectious disease, hepatitis, hepatitis A virus infection, liver disorder, viral hepatitis, viral infectious disease | Active, not recruiting | Phase 4 | 2024-08-21 | NCT06058416 |